Defense Health Agency Contracting Activity - DHACA

Description

The intent of the FY19 PRARP InCASA is to support innovative research that improves the quality of life and care for individuals living with the common symptoms of TBI and/or AD/ADRD and/or their families and care providers, as related to the PRARP’s mission (see Section II.A, Program Description). The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the PRARP’s mission and vision. This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers. The research innovations for the FY19 PRARP InCASA are expected to benefit the military, Veteran, and civilian communities. FY19 PRARP InCASA applications should be Innovation- and Impact-based. The FY19 PRARP InCASA offers two levels of funding. Funding Level I is intended to support early-career investigators within 3 years of their first independent faculty position, from any field or discipline. Note that Funding Level I applications will be required to include an Eligibility Statement (Attachment 6) in order to verify the eligibility of the individual named as the Principal Investigator (PI) for this award. Funding Level II is intended to support PIs at or above the level of assistant professor (or equivalent) from any field or discipline. The application should demonstrate the study team’s experience in both TBI and/or AD/ADRD research, as appropriate.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org